Wolverine Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.23M Sell
81,800
-33,100
-29% -$836K ﹤0.01% 2077
2025
Q2
$2.79M Sell
114,900
-72,200
-39% -$1.58M ﹤0.01% 1436
2025
Q1
$4.03M Buy
187,100
+149,100
+392% +$3.75M ﹤0.01% 1106
2024
Q4
$901K Sell
38,000
-85,700
-69% -$2.11M ﹤0.01% 2770
2024
Q3
$3.17M Sell
123,700
-1,800
-1% -$45.8K ﹤0.01% 1362
2024
Q2
$2.95M Buy
125,500
+30,000
+31% +$757K ﹤0.01% 1326
2024
Q1
$2.75M Sell
95,500
-149,100
-61% -$4.48M ﹤0.01% 1392
2023
Q4
$8.03M Buy
244,600
+38,900
+19% +$1.06M 0.01% 825
2023
Q3
$5.73M Buy
205,700
+16,600
+9% +$543K 0.01% 918
2023
Q2
$6.37M Buy
189,100
+71,800
+61% +$2.26M 0.01% 793
2023
Q1
$3.36M Sell
117,300
-105,600
-47% -$3.27M 0.01% 1054
2022
Q4
$6.29M Sell
222,900
-6,000
-3% -$190K 0.01% 778
2022
Q3
$7.53M Buy
228,900
+43,800
+24% +$1.61M 0.01% 675
2022
Q2
$5.96M Buy
+185,100
New +$6.47M 0.01% 745
2022
Q1
Sell
-166,400
Closed -$10.3M 5353
2021
Q4
$10.3M Sell
166,400
-26,100
-14% -$1.8M 0.01% 712
2021
Q3
$14.2M Buy
+192,500
New +$16.2M 0.02% 645
2021
Q2
Sell
-174,100
Closed -$14.7M 5882
2021
Q1
$14.7M Buy
+174,100
New +$17.3M 0.02% 515
2020
Q4
Sell
-9,700
Closed -$623K 4765
2020
Q3
$623K Buy
+9,700
New +$568K ﹤0.01% 2568

Other funds holding ARKG

Wolverine Trading's ARKG Position: Q3 2025 in Review

Wolverine Trading increased its ARK Genomic Revolution ETF (ARKG) stake by 11% in Q3 2025, buying an estimated $102K and bringing the position to 42,447 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Wolverine Trading first reported a position in ARKG in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.9M in Q1 2024. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Wolverine Trading held 42,447 shares of ARK Genomic Revolution ETF worth $1.16M as of Q3 2025.
  • Wolverine Trading bought 4,036 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $102K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2745 holding.
  • Wolverine Trading first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 19 quarters since.
  • Wolverine Trading's ARK Genomic Revolution ETF position peaked at $2.9M in Q1 2024.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.